Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 7-Day Trial for You or Your Team.

Learn More →

A phase I study of an anti-CD22-deglycosylated ricin A chain immunotoxin in the treatment of B-cell lymphomas resistant to conventional therapy

A phase I study of an anti-CD22-deglycosylated ricin A chain immunotoxin in the treatment of... http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Blood Unpaywall

A phase I study of an anti-CD22-deglycosylated ricin A chain immunotoxin in the treatment of B-cell lymphomas resistant to conventional therapy

Loading next page...
 
/lp/unpaywall/a-phase-i-study-of-an-anti-cd22-deglycosylated-ricin-a-chain-Si5O9mzR8Z

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Unpaywall
ISSN
0006-4971
DOI
10.1182/blood.v82.9.2624.bloodjournal8292624
Publisher site
See Article on Publisher Site

Abstract

Journal

BloodUnpaywall

Published: Nov 1, 1993

There are no references for this article.